About Us

Neuome Technologies Private Limited is a niche biotech innovation startup with proprietary technologies, and assays with wide applications in the molecular diagnostics space. We are a sustainable platform for therapeutic, prophylactic or diagnostic technologies developing Lifesciences R&D innovations.

We Endeavor to make a difference

  • Founded by an interdisciplinary scientist with impeccable credentials from leading global universities
  • International collaborations in place with  principal investigators in the U.S and E.U regions
  • Strategic plan with a scalable business model built on validated technologies, and patenting strategy.
  1. InstaDetect™ Pathogen Diagnostic Kit Platform – Instrument Free (InCov19™ / COVISPOT currently developed for COVID19)
  2. InstaPreserve RT™ Biospecimen collection, transport and storage technology with long and stable shelf life which eliminates the requirement of cold chain for collection, transport and storage. Will obviate need for capex of ULT Freezers and reduce operating expenditure.
  3. Innovation driven research services for solving pharmaceutical, biotechnology research and development problems.
  4. Genetic testing & reports development for partners – Transcell and Trugeny
  5. In silico Bioinformatics research services
  6. Clinical research consulting & data analytics




Our Team

Rajanikanth Vangala Ph.D , Managing Director & CEO

25+ years of experience in Applied and Fundamental Research. Imperial College (London), Karolinska Institute (Sweden) & Ludwig Maximilian (Munchen, Germany). DBT Govt. of India Scholarship Holder.

Subrahmanyam P (Subbu) Chief Mentor & Director on Board

Currently Founder & CEO of Tran2Digi IT Solutions & Services Private Limited., & working as an independent consultant to various startups. Prior to this he worked at Wipro Technologies, for 35 years. Retired as Senior Vice President & Chief Delivery Officer. Completed Masters in Computer Science.

Our Partners

Adipomics, Inc. was founded in 2015 with the goal of improving diagnostics and treatment around childhood obesity. Led by a Pediatric Emergency Physician and a Pediatric Bariatric Surgeon, Adipomics, Inc. works with a multidisciplinary team of physicians and scientists to address the common comorbid diseases of obesity. In particular, we focus on early onset cardiovascular disease and type 2 diabetes mellitus.

Bangalore Bioinnovation Centre (BBC) is a joint initiative of Department of Biotechnology, Government of India and Department of Electronics, IT, BT and S&T, Government of Karnataka. It works closely with Karnataka Innovation & Technology Society (KITS), a nodal centre for implementing schemes of the Department of Electronics, IT, BT and S&T, Government of Karnataka & its startup cell. It is a State-of-the-art translational research and entrepreneurship centre catering to all the needs of start-ups in life science.

The Indian Council of Medical Research (ICMR), New Delhi, the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest medical research bodies in the world. 

Located in Bangalore, India, Stellixir Biotech Pvt. Ltd is a niche preclinical R&D service provider. Vested in the hands of remarkably skilled professionals and top-notch research scientists, Stellixir integrates quality and innovation to provide rapid and reliable solutions in distinct specialties, under the umbrella of in vitro preclinical toxicity studies and stem cell research. Its core capacities include anti-cancer cell-based drug screening, predictive toxicology, biomarker analysis, 3D spheroid culture, and stem cell assay development and screening.

Transcell’s Transtoxbio vertical was created to offer human surrogate cell/tissue in vitro systems to meet the need of investigation adopting next generation and alternative approaches in preclinical, clinical testing. Transtox has unique expertise in the field of primary, progenitor cell/tissue based platform production, supply, and the specialty in vitro testing services to guide the users’ preclinical exploratory research requirement spanning the drug, vaccine, and cosmetics industry.